XML 40 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Derivatives (Tables)
3 Months Ended
Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location
The following table presents the primary underlying risk exposure, gross notional amount, and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:
 
 
 
 
March 31, 2019
 
December 31, 2018
 
 
Primary Underlying Risk Exposure
 
Gross
Notional
Amount
 
Estimated Fair Value
 
Gross
Notional
Amount
 
Estimated Fair Value
 
 
Assets
 
Liabilities
 
Assets
 
Liabilities
 
 
 
 
(In millions)
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Fair value hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
Interest rate
 
$
2,421

 
$
2,355

 
$
2

 
$
2,446

 
$
2,197

 
$
2

Foreign currency swaps
 
Foreign currency exchange rate
 
1,380

 
34

 
9

 
1,233

 
54

 

Foreign currency forwards
 
Foreign currency exchange rate
 
2,007

 
1

 
30

 
2,140

 
28

 
18

Subtotal
 
 
 
5,808

 
2,390

 
41

 
5,819

 
2,279

 
20

Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
Interest rate
 
3,882

 
164

 
6

 
3,515

 
143

 
1

Interest rate forwards
 
Interest rate
 
2,935

 

 
117

 
3,022

 

 
216

Foreign currency swaps
 
Foreign currency exchange rate
 
34,976

 
1,520

 
1,598

 
35,931

 
1,796

 
1,831

Subtotal
 
 
 
41,793

 
1,684

 
1,721

 
42,468

 
1,939

 
2,048

NIFO hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency forwards
 
Foreign currency exchange rate
 
782

 
9

 
35

 
960

 
4

 
27

Currency options
 
Foreign currency exchange rate
 
3,180

 
12

 
97

 
5,137

 
3

 
202

Subtotal
 
 
 
3,962

 
21

 
132

 
6,097

 
7

 
229

Total qualifying hedges
 
51,563

 
4,095

 
1,894

 
54,384

 
4,225

 
2,297

Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
Interest rate
 
54,331

 
2,144

 
145

 
54,891

 
1,796

 
175

Interest rate floors
 
Interest rate
 
12,701

 
106

 

 
12,701

 
102

 

Interest rate caps
 
Interest rate
 
51,138

 
82

 

 
54,575

 
154

 
1

Interest rate futures
 
Interest rate
 
2,099

 

 
4

 
2,353

 
1

 
3

Interest rate options
 
Interest rate
 
26,689

 
532

 

 
26,690

 
416

 

Interest rate forwards
 
Interest rate
 
235

 
2

 
11

 
234

 
1

 
15

Interest rate total return swaps
 
Interest rate
 
1,048

 
44

 

 
1,048

 
33

 
2

Synthetic GICs
 
Interest rate
 
26,501

 

 

 
25,700

 

 

Foreign currency swaps
 
Foreign currency exchange rate
 
13,109

 
830

 
618

 
11,388

 
884

 
458

Foreign currency forwards
 
Foreign currency exchange rate
 
13,064

 
58

 
264

 
13,417

 
198

 
213

Currency futures
 
Foreign currency exchange rate
 
860

 

 
3

 
847

 
4

 

Currency options
 
Foreign currency exchange rate
 
1,980

 
4

 

 
2,040

 
7

 

Credit default swaps — purchased
 
Credit
 
2,248

 
17

 
63

 
1,903

 
25

 
39

Credit default swaps — written
 
Credit
 
11,409

 
198

 
3

 
11,391

 
95

 
13

Equity futures
 
Equity market
 
3,687

 
3

 
18

 
2,992

 
13

 
77

Equity index options
 
Equity market
 
27,880

 
663

 
649

 
27,707

 
884

 
550

Equity variance swaps
 
Equity market
 
2,269

 
43

 
92

 
2,269

 
40

 
87

Equity total return swaps
 
Equity market
 
767

 
1

 
52

 
929

 
91

 

Total non-designated or nonqualifying derivatives
 
252,015

 
4,727

 
1,922

 
253,075

 
4,744

 
1,633

Total
 
 
 
$
303,578

 
$
8,822

 
$
3,816

 
$
307,459

 
$
8,969

 
$
3,930

Components of Net Derivatives Gains (Losses)
The following table presents the consolidated financial statement location and amount of gain (loss) recognized on fair value, cash flow, NIFO, nonqualifying hedging relationships and embedded derivatives:
 
 
Three Months Ended March 31, 2019
 
 
Net Investment Income
 
Net Investment Gains (Losses)
 
Net Derivative Gains (Losses)
 
Policyholder Benefits and Claims
 
Interest Credited to Policyholder Account Balances
 
Other Expenses
 
OCI
 
 
(In millions)
Gain (Loss) on Fair Value Hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments (1)
 
$
(3
)
 
$

 
$

 
$
127

 
$

 
$

 
N/A

Hedged items
 
3

 

 

 
(128
)
 

 

 
N/A

Foreign currency exchange rate derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments (1)
 
(30
)
 
(14
)
 

 

 

 

 
N/A

Hedged items
 
29

 
12

 

 

 

 

 
N/A

Amount excluded from the assessment of hedge effectiveness
 

 
(16
)
 

 

 

 

 
N/A

Subtotal
 
(1
)

(18
)



(1
)
 

 

 
N/A

Gain (Loss) on Cash Flow Hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate derivatives: (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of gains (losses) deferred in AOCI
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
$
252

Amount of gains (losses) reclassified from AOCI into income
 
5

 
(6
)
 

 

 

 
1

 

Foreign currency exchange rate derivatives: (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of gains (losses) deferred in AOCI
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
(241
)
Amount of gains (losses) reclassified from AOCI into income
 
(2
)
 
25

 

 

 

 

 
(23
)
Foreign currency transaction gains (losses) on hedged items
 

 
(35
)
 

 

 

 

 

Credit derivatives: (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of gains (losses) deferred in AOCI
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 

Amount of gains (losses) reclassified from AOCI into income
 

 
1

 

 

 

 

 
(1
)
Subtotal
 
3

 
(15
)
 

 

 

 
1

 
(13
)
Gain (Loss) on NIFO Hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency exchange rate derivatives (1)
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
(6
)
Subtotal
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
(6
)
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate derivatives (1)
 
(1
)
 

 
409

 
19

 

 

 
N/A

Foreign currency exchange rate derivatives (1)
 

 

 
(142
)
 
3

 

 

 
N/A

Credit derivatives — purchased (1)
 

 

 
(15
)
 

 

 

 
N/A

Credit derivatives — written (1)
 

 

 
136

 

 

 

 
N/A

Equity derivatives (1)
 

 

 
(667
)
 
(96
)
 

 

 
N/A

Foreign currency transaction gains (losses) on hedged items
 

 

 
82

 

 

 

 
N/A

Subtotal
 
(1
)
 

 
(197
)
 
(74
)
 

 

 
N/A

Earned income on derivatives
 
56

 

 
119

 
32

 
(32
)
 

 

Embedded derivatives (2)
 
N/A

 
N/A

 
193

 

 
N/A

 
N/A

 
N/A

Total
 
$
57

 
$
(33
)
 
$
115

 
$
(43
)
 
$
(32
)
 
$
1

 
$
(19
)

 
 
Three Months Ended March 31, 2018
 
 
Net Investment Income
 
Net Investment Gains (Losses)
 
Net Derivative Gains (Losses)
 
Policyholder Benefits and Claims
 
Interest Credited to Policyholder Account Balances
 
Other Expenses
 
OCI
 
 
(In millions)
Gain (Loss) on Fair Value Hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments (1)
 
$

 
$

 
$
(210
)
 
$

 
$

 
$

 
N/A

Hedged items
 

 

 
210

 

 

 

 
N/A

Foreign currency exchange rate derivatives:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments (1)
 

 

 
170

 

 

 

 
N/A

Hedged items
 

 

 
(159
)
 

 

 

 
N/A

Amount excluded from the assessment of hedge effectiveness
 

 

 
(8
)
 

 

 

 
N/A

Subtotal
 

 

 
3

 

 

 

 
N/A

Gain (Loss) on Cash Flow Hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate derivatives: (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of gains (losses) deferred in AOCI
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
$
(277
)
Amount of gains (losses) reclassified from AOCI into income
 
4

 

 
21

 

 

 

 
(25
)
Foreign currency exchange rate derivatives: (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of gains (losses) deferred in AOCI
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
(75
)
Amount of gains (losses) reclassified from AOCI into income
 

 

 
139

 

 

 
1

 
(140
)
Foreign currency transaction gains (losses) on hedged items
 

 

 
(138
)
 

 

 

 

Credit derivatives: (1)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of gains (losses) deferred in AOCI
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 

Amount of gains (losses) reclassified from AOCI into income
 

 

 

 

 

 

 

Subtotal
 
4

 

 
22

 

 

 
1

 
(517
)
Gain (Loss) on NIFO Hedges:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency exchange rate derivatives (1)
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
(157
)
Subtotal
 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
N/A

 
(157
)
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate derivatives (1)
 
4

 

 
(235
)
 
(7
)
 

 

 
N/A

Foreign currency exchange rate derivatives (1)
 

 

 
387

 
2

 

 

 
N/A

Credit derivatives — purchased (1)
 

 

 
(3
)
 

 

 

 
N/A

Credit derivatives — written (1)
 

 

 
(44
)
 

 

 

 
N/A

Equity derivatives (1)
 
1

 

 
98

 
12

 

 

 
N/A

Foreign currency transaction gains (losses) on hedged items
 

 

 
(49
)
 

 

 

 
N/A

Subtotal
 
5

 

 
154

 
7

 

 

 
N/A

Earned income on derivatives
 
81

 

 
133

 
2

 
(23
)
 
(2
)
 

Embedded derivatives (2)
 
N/A

 
N/A

 
37

 

 
N/A

 
N/A

 
N/A

Total
 
$
90

 
$

 
$
349

 
$
9

 
$
(23
)
 
$
(1
)
 
$
(674
)
__________________
(1)
Excludes earned income on derivatives.
(2)
The valuation of guaranteed minimum benefits includes a nonperformance risk adjustment. The amounts included in net derivative gains (losses) in connection with this adjustment were ($62) million and $20 million for the three months ended March 31, 2019 and 2018, respectively.
Net derivatives gains (losses) recognized on fair value derivatives and the related hedged items
The following table presents the balance sheet classification, carrying amount and cumulative fair value hedging adjustments for items designated and qualifying as hedged items in fair value hedges:
 
 
March 31, 2019
Balance Sheet Line Item
 
Carrying Amount
 of the Hedged
Assets/(Liabilities)
 
Cumulative Amount
of Fair Value Hedging Adjustments
Included in the Carrying Amount of Hedged
Assets/(Liabilities) (1)
 
 
(In millions)
Fixed maturity securities AFS
 
$
2,227

 
$
(1
)
Mortgage loans
 
$
1,245

 
$
(1
)
Future policy benefits
 
$
(5,399
)
 
$
(667
)
Policyholder account balances
 
$
(81
)
 
$

__________________
(1)
Includes ($1) million of hedging adjustments on discontinued hedging relationships.
Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:
 
 
March 31, 2019
 
December 31, 2018
Rating Agency Designation of Referenced
Credit Obligations (1)
 
Estimated
Fair Value
of Credit
Default
Swaps
 
Maximum
Amount of Future
Payments under
Credit Default
Swaps
 
Weighted
Average
Years to
Maturity (2)
 
Estimated
Fair Value
of Credit
Default
Swaps
 
Maximum
Amount of Future
Payments under
Credit Default
Swaps
 
Weighted
Average
Years to
Maturity (2)
 
 
(Dollars in millions)
Aaa/Aa/A
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps (3)
 
$
5

 
$
391

 
1.5

 
$
4

 
$
354

 
1.7

Credit default swaps referencing indices
 
33

 
2,317

 
2.4

 
28

 
2,154

 
2.5

Subtotal
 
38

 
2,708

 
2.3

 
32

 
2,508

 
2.4

Baa
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps (3)
 
3

 
404

 
1.4

 
3

 
482

 
1.5

Credit default swaps referencing indices
 
133

 
7,957

 
5.3

 
40

 
8,056

 
5.0

Subtotal
 
136

 
8,361

 
5.1

 
43

 
8,538

 
4.8

Ba
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps (3)
 

 
10

 
1.2

 

 
15

 
2.0

Credit default swaps referencing indices
 

 

 

 

 

 

Subtotal
 

 
10

 
1.2

 

 
15

 
2.0

B
 
 
 
 
 
 
 
 
 
 
 
 
Single name credit default swaps (3)
 

 

 

 

 

 

Credit default swaps referencing indices
 
21

 
330

 
5.2

 
7

 
330

 
5.0

Subtotal
 
21

 
330

 
5.2

 
7

 
330

 
5.0

Total
 
$
195

 
$
11,409

 
4.4

 
$
82

 
$
11,391

 
4.3

__________________
(1)
The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service (“Moody’s”), S&P Global Ratings (“S&P”) and Fitch Ratings. If no rating is available from a rating agency, then an internally developed rating is used.
(2)
The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.
(3)
Single name credit default swaps may be referenced to the credit of corporations, foreign governments, or state and political subdivisions.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
Credit Risk on Freestanding Derivatives
The Company may be exposed to credit-related losses in the event of nonperformance by its counterparties to derivatives. Generally, the current credit exposure of the Company’s derivatives is limited to the net positive estimated fair value of derivatives at the reporting date after taking into consideration the existence of master netting or similar agreements and any collateral received pursuant to such agreements.
The Company manages its credit risk related to derivatives by entering into transactions with creditworthy counterparties and establishing and monitoring exposure limits. The Company’s OTC-bilateral derivative transactions are governed by ISDA Master Agreements which provide for legally enforceable set-off and close-out netting of exposures to specific counterparties in the event of early termination of a transaction, which includes, but is not limited to, events of default and bankruptcy. In the event of an early termination, the Company is permitted to set off receivables from the counterparty against payables to the same counterparty arising out of all included transactions. Substantially all of the Company’s ISDA Master Agreements also include Credit Support Annex provisions which require both the pledging and accepting of collateral in connection with its OTC-bilateral derivatives.
The Company’s OTC-cleared derivatives are effected through central clearing counterparties and its exchange-traded derivatives are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis (both initial margin and variation margin), and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to such derivatives.
See Note 7 for a description of the impact of credit risk on the valuation of derivatives.
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
 
 
March 31, 2019
 
December 31, 2018
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement 
 
Assets
 
Liabilities
 
Assets
 
Liabilities
 
 
(In millions)
Gross estimated fair value of derivatives:
 
 
 
 
 
 
 
 
OTC-bilateral (1)
 
$
8,485

 
$
3,747

 
$
8,805

 
$
3,758

OTC-cleared (1)
 
435

 
37

 
245

 
33

Exchange-traded
 
3

 
25

 
18

 
80

Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
 
8,923

 
3,809

 
9,068

 
3,871

Gross amounts not offset on the interim condensed consolidated balance sheets:
 
 
 
 
 
 
 
 
Gross estimated fair value of derivatives: (2)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(2,590
)
 
(2,590
)
 
(2,570
)
 
(2,570
)
OTC-cleared
 
(22
)
 
(22
)
 
(25
)
 
(25
)
Exchange-traded
 

 

 
(1
)
 
(1
)
Cash collateral: (3), (4)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(3,613
)
 

 
(4,709
)
 

OTC-cleared
 
(390
)
 
(6
)
 
(145
)
 

Exchange-traded
 

 
(12
)
 

 
(57
)
Securities collateral: (5)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(2,080
)
 
(1,126
)
 
(1,266
)
 
(1,134
)
OTC-cleared
 

 
(7
)
 

 
(8
)
Exchange-traded
 

 
(12
)
 

 
(7
)
Net amount after application of master netting agreements and collateral
 
$
228

 
$
34

 
$
352

 
$
69

__________________
(1)
At March 31, 2019 and December 31, 2018, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $101 million and $99 million, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($7) million and ($59) million, respectively.
(2)
Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)
Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.
(4)
The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2019 and December 31, 2018, the Company received excess cash collateral of $139 million and $135 million, respectively, and provided excess cash collateral of $275 million and $226 million, respectively, which is not included in the table above due to the foregoing limitation.
(5)
Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at March 31, 2019, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At March 31, 2019 and December 31, 2018, the Company received excess securities collateral with an estimated fair value of $74 million and $70 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At March 31, 2019 and December 31, 2018, the Company provided excess securities collateral with an estimated fair value of $173 million and $212 million, respectively, for its OTC-bilateral derivatives, and $639 million and $601 million, respectively, for its OTC-cleared derivatives, and $115 million and $90 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
 
 
March 31, 2019
 
December 31, 2018
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement 
 
Assets
 
Liabilities
 
Assets
 
Liabilities
 
 
(In millions)
Gross estimated fair value of derivatives:
 
 
 
 
 
 
 
 
OTC-bilateral (1)
 
$
8,485

 
$
3,747

 
$
8,805

 
$
3,758

OTC-cleared (1)
 
435

 
37

 
245

 
33

Exchange-traded
 
3

 
25

 
18

 
80

Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
 
8,923

 
3,809

 
9,068

 
3,871

Gross amounts not offset on the interim condensed consolidated balance sheets:
 
 
 
 
 
 
 
 
Gross estimated fair value of derivatives: (2)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(2,590
)
 
(2,590
)
 
(2,570
)
 
(2,570
)
OTC-cleared
 
(22
)
 
(22
)
 
(25
)
 
(25
)
Exchange-traded
 

 

 
(1
)
 
(1
)
Cash collateral: (3), (4)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(3,613
)
 

 
(4,709
)
 

OTC-cleared
 
(390
)
 
(6
)
 
(145
)
 

Exchange-traded
 

 
(12
)
 

 
(57
)
Securities collateral: (5)
 
 
 
 
 
 
 
 
OTC-bilateral
 
(2,080
)
 
(1,126
)
 
(1,266
)
 
(1,134
)
OTC-cleared
 

 
(7
)
 

 
(8
)
Exchange-traded
 

 
(12
)
 

 
(7
)
Net amount after application of master netting agreements and collateral
 
$
228

 
$
34

 
$
352

 
$
69

__________________
(1)
At March 31, 2019 and December 31, 2018, derivative assets included income or (expense) accruals reported in accrued investment income or in other liabilities of $101 million and $99 million, respectively, and derivative liabilities included (income) or expense accruals reported in accrued investment income or in other liabilities of ($7) million and ($59) million, respectively.
(2)
Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)
Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet.
(4)
The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2019 and December 31, 2018, the Company received excess cash collateral of $139 million and $135 million, respectively, and provided excess cash collateral of $275 million and $226 million, respectively, which is not included in the table above due to the foregoing limitation.
(5)
Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at March 31, 2019, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At March 31, 2019 and December 31, 2018, the Company received excess securities collateral with an estimated fair value of $74 million and $70 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At March 31, 2019 and December 31, 2018, the Company provided excess securities collateral with an estimated fair value of $173 million and $212 million, respectively, for its OTC-bilateral derivatives, and $639 million and $601 million, respectively, for its OTC-cleared derivatives, and $115 million and $90 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Derivative Instruments, Gain (Loss) [Line Items]  
Schedule of Derivative Instruments
 
 
March 31, 2019
 
December 31, 2018
 
 
Derivatives
Subject to
Credit-
Contingent
Provisions
 
Derivatives
Not Subject
to Credit-
Contingent
Provisions
 
Total
 
Derivatives
Subject to
Credit-
Contingent
Provisions
 
Derivatives
Not Subject
to Credit-
Contingent
Provisions
 
Total
 
 
(In millions)
Estimated Fair Value of Derivatives in a Net Liability Position (1)
 
$
1,135

 
$
21

 
$
1,156

 
$
1,148

 
$
40

 
$
1,188

Estimated Fair Value of Collateral Provided:
 
 
 
 
 
 
 
 
 
 
 
 
Fixed maturity securities AFS
 
$
1,223

 
$
9

 
$
1,232

 
$
1,218

 
$
9

 
$
1,227

Cash
 
$

 
$

 
$

 
$
6

 
$

 
$
6

__________________
(1)
After taking into consideration the existence of netting agreements.
Embedded Derivative Financial Instruments [Member]  
Derivative Instruments, Gain (Loss) [Line Items]  
Schedule of Derivative Instruments
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
 
 
Balance Sheet Location
 
March 31, 2019
 
December 31, 2018
 
 
 
 
(In millions)
Embedded derivatives within asset host contracts:
 
 
 
 
 
 
Ceded guaranteed minimum benefits
 
Premiums, reinsurance and other receivables
 
$
69

 
$
71

Embedded derivatives within liability host contracts:
 
 
 
 
 
 
Direct guaranteed minimum benefits
 
Policyholder account balances
 
$
182

 
$
298

Assumed guaranteed minimum benefits
 
Policyholder account balances
 
393

 
495

Funds withheld on ceded reinsurance
 
Other liabilities
 
4

 
(41
)
Fixed annuities with equity indexed returns
 
Policyholder account balances
 
95

 
58

Embedded derivatives within liability host contracts
 
$
674

 
$
810